Eam Investors, LLC Revance Therapeutics, Inc. Transaction History

Eam Investors, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jul 12, 2023	BUY	$18.36 - $35.27 $1.47 Million - $2.82 Million	79,905 New	79,905 $2.57 Million
Q3 2022 Nov 14, 2022	BUY	$14.33 - $28.47 $1.35 Million - $2.69 Million	94,413 New	94,413 $2.55 Million
Q4 2020 Feb 11, 2021	SELL	$23.41 - $28.34 $995,791 - $1.21 Million	-42,537 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$23.23 - $34.3 $255,181 - $376,785	10,985 Added 34.82%	42,537 $1.07 Million
Q2 2020 Aug 13, 2020	SELL	$12.6 - $26.55 $677,250 - $1.43 Million	-53,750 Reduced 63.01%	31,552 $770,000
Q1 2020 May 13, 2020	SELL	$12.46 - $27.81 $250,782 - $559,731	-20,127 Reduced 19.09%	85,302 $1.26 Million
Q4 2019 Feb 11, 2020	BUY	$11.66 - $20.15 $1.23 Million - $2.12 Million	105,429 New	105,429 $1.71 Million
Q2 2018 Aug 03, 2018	SELL	$27.45 - $33.35 $3.1 Million - $3.77 Million	-113,096 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$29.15 - $37.4 $167,991 - $215,536	5,763 Added 5.37%	113,096 $3.48 Million
Q4 2017 May 21, 2018	SELL	$24.55 - $36.3 $1.1 Million - $1.63 Million	-44,898 Reduced 29.49%	107,333 $3.84 Million
Q4 2017 Feb 12, 2018	BUY	$24.55 - $36.3 $1.96 Million - $2.89 Million	79,713 Added 109.92%	152,231 $5.44 Million
Q3 2017 Nov 08, 2017	BUY	$22.55 - $28.1 $1.64 Million - $2.04 Million	72,518	72,518 $2 Million

232

82.1M

680K

896K

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.